-
1
-
-
67649632034
-
Diagnosis and assessment of pulmonary arterial hypertension
-
Badesch DB, Champion HC, Sanchez MA, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol. 2009;54(1)(Suppl):S55-S66.
-
(2009)
J Am Coll Cardiol
, vol.54
, Issue.1 SUPPL.
-
-
Badesch, D.B.1
Champion, H.C.2
Sanchez, M.A.3
-
2
-
-
66549127501
-
ACCF/AHA 2009 expert consensus document on pulmonary hypertension: A report of the American College of Cardio logy Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Asso ciation
-
ACCF/AHA
-
McLaughlin VV, Archer SL, Badesch DB, et al ACCF/AHA. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardio logy Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Asso ciation. Circulation. 2009;119(16):2250-2294.
-
(2009)
Circulation
, vol.119
, Issue.16
, pp. 2250-2294
-
-
McLaughlin, V.V.1
Archer, S.L.2
Badesch, D.B.3
-
3
-
-
49249111028
-
Design of the REVEAL registry for US patients with pulmonary arterial hypertension
-
McGoon MD, Krichman A, Farber HW, et al. Design of the REVEAL registry for US patients with pulmonary arterial hypertension. Mayo Clin Proc. 2008;83(8):923-931.
-
(2008)
Mayo Clin Proc
, vol.83
, Issue.8
, pp. 923-931
-
-
McGoon, M.D.1
Krichman, A.2
Farber, H.W.3
-
4
-
-
78651415646
-
The changing picture of pulmonary arterial hypertension (PAH) patients in the United States: How the REVEAL registry differs from historic and non-US contemporary registries
-
Frost AE, Badesch DB, Barst RJ, et al. The changing picture of pulmonary arterial hypertension (PAH) patients in the United States: how the REVEAL registry differs from historic and non-US contemporary registries. Chest. 2011;139(1):128-137.
-
(2011)
Chest
, vol.139
, Issue.1
, pp. 128-137
-
-
Frost, A.E.1
Badesch, D.B.2
Barst, R.J.3
-
5
-
-
67649579669
-
Updated clin ical classification of pulmonary hypertension
-
Simonneau G, Robbins IM, Beghetti M, et al. Updated clin ical classification of pulmonary hypertension. J Am Coll Cardiol. 2009;54(1)(suppl):S43-S54.
-
(2009)
J Am Coll Cardiol
, vol.54
, Issue.1 SUPPL.
-
-
Simonneau, G.1
Robbins, I.M.2
Beghetti, M.3
-
6
-
-
0033767552
-
Pulmonary arterial hypertension in patients with sleep apnoea syndrome
-
Bady E, Achkar A, Pascal S, Orvoen-Frija E, Laaban JP. Pulmonary arterial hypertension in patients with sleep apnoea syndrome. Thorax. 2000;55(11):934-939.
-
(2000)
Thorax
, vol.55
, Issue.11
, pp. 934-939
-
-
Bady, E.1
Achkar, A.2
Pascal, S.3
Orvoen-Frija, E.4
Laaban, J.P.5
-
7
-
-
0029949783
-
Pulmonary hypertension in the obstructive sleep apnoea syndrome: Prevalence, causes and therapeutic consequences
-
DOI 10.1183/09031936.96.09040787
-
Kessler R, Chaouat A, Weitzenblum E, et al. Pulmonary hypertension in the obstructive sleep apnoea syndrome: prevalence, causes and therapeutic consequences. Eur Respir J. 1996;9(4):787-794. (Pubitemid 26167887)
-
(1996)
European Respiratory Journal
, vol.9
, Issue.4
, pp. 787-794
-
-
Kessler, R.1
Chaouat, A.2
Weitzenblum, E.3
Oswald, M.4
Ehrhart, M.5
Apprill, M.6
Krieger, J.7
-
8
-
-
33846330126
-
Unexplained pulmonary hypertension in elderly patients
-
DOI 10.1378/chest.06-1571
-
Shapiro BP, McGoon MD, Redfield MM. Unexplained pulmonary hypertension in elderly patients. Chest. 2007;131(1): 94-100. (Pubitemid 46122979)
-
(2007)
Chest
, vol.131
, Issue.1
, pp. 94-100
-
-
Shapiro, B.P.1
McGoon, M.D.2
Redfield, M.M.3
-
9
-
-
77956899988
-
Determinants and prognostic value of pulmonary arterial pressure in patients with chronic heart failure
-
Damy T, Goode KM, Kallvikbacka-Bennett A, et al. Determinants and prognostic value of pulmonary arterial pressure in patients with chronic heart failure. Eur Heart J. 2010;31(18):2280-2290.
-
(2010)
Eur Heart J
, vol.31
, Issue.18
, pp. 2280-2290
-
-
Damy, T.1
Goode, K.M.2
Kallvikbacka-Bennett, A.3
-
10
-
-
0030853952
-
A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST)
-
DOI 10.1016/S0002-8703(97)70105-4
-
Califf RM, Adams KF, McKenna WJ, et al. A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST). Am Heart J. 1997;134(1):44-54. (Pubitemid 27329022)
-
(1997)
American Heart Journal
, vol.134
, Issue.1
, pp. 44-54
-
-
Califf, R.M.1
Adams, K.F.2
McKenna, W.J.3
Gheorghiade, M.4
Uretsky, B.F.5
McNulty, S.E.6
Darius, H.7
Schulman, K.8
Zannad, F.9
Handberg-Thurmond, E.10
Harrell Jr., F.E.11
Wheeler, W.12
Soler-Soler, J.13
Swedberg, K.14
-
11
-
-
76749135710
-
Pulmonary arterial hypertension: Baseline characteristics from the REVEAL Registry
-
Badesch DB, Raskob GE, Elliott CG, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest. 2010;137(2):376-387.
-
(2010)
Chest
, vol.137
, Issue.2
, pp. 376-387
-
-
Badesch, D.B.1
Raskob, G.E.2
Elliott, C.G.3
-
12
-
-
2942522878
-
Clinical classification of pulmonary hypertension
-
DOI 10.1016/j.jacc.2004.02.037, PII S0735109704004759
-
Simonneau G, Galiè N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2004;43(12 Suppl S):5S-12S. (Pubitemid 38759712)
-
(2004)
Journal of the American College of Cardiology
, vol.43
, Issue.12 SUPPL.
-
-
Simonneau, G.1
Galie, N.2
Rubin, L.J.3
Langleben, D.4
Seeger, W.5
Domenighetti, G.6
Gibbs, S.7
Lebrec, D.8
Speich, R.9
Beghetti, M.10
Rich, S.11
Fishman, A.12
-
13
-
-
33947227921
-
Immortal time bias in observational studies of drug effects
-
DOI 10.1002/pds.1357
-
Suissa S. Immortal time bias in observational studies of drug effects. Pharmacoepidemiol Drug Saf. 2007;16(3):241-249. (Pubitemid 46431687)
-
(2007)
Pharmacoepidemiology and Drug Safety
, vol.16
, Issue.3
, pp. 241-249
-
-
Suissa, S.1
-
14
-
-
0001137256
-
A note on the product-limit estimator under right censoring and left truncation
-
Tsai W, Jewell N, Wang M. A note on the product-limit estimator under right censoring and left truncation. Biometrika. 1987;74(4):883-886.
-
(1987)
Biometrika
, vol.74
, Issue.4
, pp. 883-886
-
-
Tsai, W.1
Jewell, N.2
Wang, M.3
-
15
-
-
0031570013
-
Survival analysis in observational studies
-
Bull K, Spiegelhalter DJ. Survival analysis in observational studies. Stat Med. 1997;16(9):1041-1074.
-
(1997)
Stat Med
, vol.16
, Issue.9
, pp. 1041-1074
-
-
Bull, K.1
Spiegelhalter, D.J.2
-
16
-
-
3242810591
-
Long-term effects of darusentan on left-ventricular remod elling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): Randomised, double-blind, placebo-controlled trial
-
EARTH investigators.
-
Anand I, McMurray J, Cohn JN, et al; EARTH investigators. Long-term effects of darusentan on left-ventricular remod elling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial. Lancet. 2004;364(9431):347-354.
-
(2004)
Lancet
, vol.364
, Issue.9431
, pp. 347-354
-
-
Anand, I.1
McMurray, J.2
Cohn, J.N.3
-
17
-
-
20844459311
-
Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: Results of a pilot study
-
DOI 10.1016/j.cardfail.2004.05.006
-
Packer M, McMurray J, Massie BM, et al. Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study. J Card Fail. 2005;11(1):12-20. (Pubitemid 40215308)
-
(2005)
Journal of Cardiac Failure
, vol.11
, Issue.1
, pp. 12-20
-
-
Packer, M.1
McMurray, J.2
Massie, B.M.3
Caspi, A.4
Charlon, V.5
Cohen-Solal, A.6
Kiowski, W.7
Kostuk, W.8
Krum, H.9
Levine, B.10
Rizzon, P.11
Soler, J.12
Swedberg, K.13
Anderson, S.14
Demets, D.L.15
-
18
-
-
0036023198
-
Recent heart failure trials of neurohormonal modulation (OVERTURE and ENABLE): Approaching the asymptote of efficacy?
-
DOI 10.1054/jcaf.2002.126486
-
Teerlink JR. Recent heart failure trials of neurohormonal modulation (OVERTURE and ENABLE): approaching the asymptote of efficacy? J Card Fail. 2002;8(3):124-127. (Pubitemid 34857276)
-
(2002)
Journal of Cardiac Failure
, vol.8
, Issue.3
, pp. 124-127
-
-
Teerlink, J.R.1
-
19
-
-
40149087049
-
Clinical and hemodynamic effects of bosentan dose optimization in symptomatic heart failure patients with severe systolic dysfunction, associated with secondary pulmonary hypertension - A multi-center randomized study
-
DOI 10.1159/000107791
-
Kaluski E, Cotter G, Leitman M, et al. Clinical and hemodynamic effects of bosentan dose optimization in symptomatic heart failure patients with severe systolic dysfunction, associated with secondary pulmonary hypertension-a multicenter randomized study. Cardiology. 2008;109(4):273-280. (Pubitemid 351328923)
-
(2008)
Cardiology
, vol.109
, Issue.4
, pp. 273-280
-
-
Kaluski, E.1
Cotter, G.2
Leitman, M.3
Milo-Cotter, O.4
Krakover, R.5
Kobrin, I.6
Moriconi, T.7
Rainisio, M.8
Caspi, A.9
Reizin, L.10
Zimlichman, R.11
Vered, Z.12
-
20
-
-
67650786508
-
Association of the metabolic syndrome with pulmonary venous hypertension
-
Robbins IM, Newman JH, Johnson RF, et al. Association of the metabolic syndrome with pulmonary venous hypertension. Chest. 2009;136(1):31-36.
-
(2009)
Chest
, vol.136
, Issue.1
, pp. 31-36
-
-
Robbins, I.M.1
Newman, J.H.2
Johnson, R.F.3
-
21
-
-
34147206842
-
Prognostic Importance of Pulmonary Hypertension in Patients With Heart Failure
-
DOI 10.1016/j.amjcard.2006.11.052, PII S0002914907000598
-
Kjaergaard J, Akkan D, Iversen KK, et al. Prognostic importance of pulmonary hypertension in patients with heart failure. Am J Cardiol. 2007;99(8):1146-1150. (Pubitemid 46578202)
-
(2007)
American Journal of Cardiology
, vol.99
, Issue.8
, pp. 1146-1150
-
-
Kjaergaard, J.1
Akkan, D.2
Iversen, K.K.3
Kjoller, E.4
Kober, L.5
Torp-Pedersen, C.6
Hassager, C.7
|